These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 440977)
1. [Effect of 1-alpha-hydroxycholecalciferol (1 alpha-OH/D3) and 24,25-dihydroxycholecalciferol (24, 25-OH)2D3) on calcium and phosphorus metabolism in chronic renal failure]. Galus K; Szymendera J; Jelińska S; Schabowska M; Jelonek A Pol Arch Med Wewn; 1979 Feb; 61(2):105-12. PubMed ID: 440977 [No Abstract] [Full Text] [Related]
2. Is 24,25-dihydroxycholecalciferol a calcium-regulating hormone in man? Kanis JA; Cundy T; Bartlett M; Smith R; Heynen G; Warner GT; Russell RG Br Med J; 1978 May; 1(6124):1382-6. PubMed ID: 647302 [TBL] [Abstract][Full Text] [Related]
3. Comparison of effects of 1 alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 in man. Brickman AS; Coburn JW; Friedman GR; Okamura WH; Massry SG; Norman AW J Clin Invest; 1976 Jun; 57(6):1540-7. PubMed ID: 932193 [TBL] [Abstract][Full Text] [Related]
4. [Comparative study of the effects of alpha-25-dihydroxycholecalciferol and 24, 25-dihydroxycholecalciferol on calcium-phosphorus metabolism and on bone tissue in experimental kidney insufficiency in rats]. Alekseeva AI; Spirichev VB; Bogoslovskiĭ NA; Kisel'nikova TA Vopr Med Khim; 1983; 29(5):103-12. PubMed ID: 6606264 [TBL] [Abstract][Full Text] [Related]
5. Effect of 1 alpha-hydroxyvitamin D3 and dietary calcium and phosphate on the aortic mineral content in rabbits with mild azotemia. Tvedegaard E; Ladefoged O; Nielsen M; Kamstrup O Nephron; 1983; 34(3):185-91. PubMed ID: 6877450 [TBL] [Abstract][Full Text] [Related]
6. Intestinal phosphate absorption in normal and uremic man: effects of 1,25(OH)2-vitamin D3 and 1alpha(OH)-vitamin D3. Coburn JW; Brickman AS; Hartenbower DL; Norman AW Adv Exp Med Biol; 1977; 81():549-57. PubMed ID: 899939 [No Abstract] [Full Text] [Related]
7. 1,25-Dihydroxycholecalciferol effect on serum phosphorus homeostasis in rats. Garabedian M; Pezant E; Miravet L; Fellot C; Balsan S Endocrinology; 1976 Mar; 98(3):794-9. PubMed ID: 1261499 [TBL] [Abstract][Full Text] [Related]
8. Effect of 25-hydroxy-vitamin D3 on intestinal absorption of calcium in normal man and patients with renal failure. Colodro IH; Brickman AS; Coburn JW; Osborn TW; Norman AW Metabolism; 1978 Jun; 27(6):745-53. PubMed ID: 651659 [TBL] [Abstract][Full Text] [Related]
9. 1-alpha-hydroxyvitamin D3 in chronic renal failure. A potent analogue of the kidney hormone, 1,25-dihydroxycholecalciferol. Chan JC; Oldham SB; Holick MF; DeLuca HF JAMA; 1975 Oct; 234(1):47-52. PubMed ID: 1174223 [TBL] [Abstract][Full Text] [Related]
10. Zinc metabolism in patients with chronic renal failure during treatment with 1.25-dihydroxycholecalciferol: a controlled therapeutic trial. Kiilerich S; Christiansen C; Christensen MS; Naestoft J Clin Nephrol; 1981 Jan; 15(1):23-7. PubMed ID: 7214749 [TBL] [Abstract][Full Text] [Related]
11. Circulating 1,25-dihydroxycholecalciferol after intravenous injections of 1 alpha-hydroxycholecalciferol in patients on regular haemodialysis. Papapoulos SE; vd Berg H; Frölich M; Valentijn RM Nephrol Dial Transplant; 1988; 3(5):647-50. PubMed ID: 3146722 [TBL] [Abstract][Full Text] [Related]
12. Effects of 1alpha,25-dihydroxyvitamin D3 and Solanum glaucophyllum on intestinal calcium and phosphate transport and on plasma Ca, Mg and P levels in the rat. Walling MW; Kimberg DV Endocrinology; 1975 Dec; 97(6):1567-76. PubMed ID: 1204578 [TBL] [Abstract][Full Text] [Related]
13. [Intestinal absorption of Ca47 in chronic renal insufficiency before and after treatment with 1,25 dihydroxycholecalciferol]. Vattimo A Minerva Med; 1979 Dec; 70(54):3705-7. PubMed ID: 523001 [TBL] [Abstract][Full Text] [Related]
14. Calcium and phosphate metabolism in chronic renal failure, with particular reference to the effect of 1 alpha-hydroxyvitamin D3. Madsen S Acta Med Scand Suppl; 1980; 638():3-120. PubMed ID: 6929650 [No Abstract] [Full Text] [Related]
15. 1 alpha hydroxycholecalciferol and 25 hydroxycholecalciferol in renal bone disease. Fournier AE; Bordier PJ; Gueris J; Chanard J; Marie P; Ferriere C; Osario M; Bedrossian J; de Luca HF Proc Eur Dial Transplant Assoc; 1976; 12():227-36. PubMed ID: 935115 [TBL] [Abstract][Full Text] [Related]
16. Effect of 25-hydroxycholecalciferol on calcium absorption in chronic renal disease. Rutherford WE; Blondin J; Hruska K; Kopelman R; Klahr S; Slatopolsky E Kidney Int; 1975 Nov; 8(5):320-4. PubMed ID: 1195563 [TBL] [Abstract][Full Text] [Related]
17. Deterioration of renal function in non-dialytic uraemics caused by 1 alpha (OH)D3 which was not attributable to hypercalcaemia. Yoshiyama N; Akiba T; Matsui N; Iwamoto H; Ogura M; Nakagawa S; Takeuchi J Proc Eur Dial Transplant Assoc; 1980; 17():569-74. PubMed ID: 7243799 [TBL] [Abstract][Full Text] [Related]
18. Effect of 1alpha-hydroxycholecalciferol, 1,25-dihydroxycholecalciferol, 3 deoxy-1alpha-hydroxycholecalciferol, 24R, 25-dihydroxycholecalciferol and successful renal transplantation on calcium absorption in haemodialysis patients. Pierides AM; Aljama P; Kerr DN; Scott M; Norman AW Nephron; 1978; 20(4):203-11. PubMed ID: 345140 [TBL] [Abstract][Full Text] [Related]
19. Absorption of calcium, magnesium and phosphate during chronic renal failure and the effect of vitamin D in rabbits. Tvedegaard E Z Versuchstierkd; 1985; 27(3-4):163-8. PubMed ID: 4050164 [No Abstract] [Full Text] [Related]
20. Effects of 25-hydroxycholecalciferol on calcium metabolism in chronic renal failure. Letteri JM; Kleinman LM; Ellis KN; Caselnova R; Akhtar M; Cohn SH Adv Exp Med Biol; 1977; 81():591-601. PubMed ID: 899943 [No Abstract] [Full Text] [Related] [Next] [New Search]